Lixoft Adds New Bioequivalence Module in MonolixSuite® Version 2021R1

Go back to Lixoft Adds New Bioequivalence Module in MonolixSuite® Version 2021R1

Simulations Plus (SLP) PT Raised to $55 at Craig-Hallum

January 7, 2022 9:21 AM EST

Craig-Hallum analyst Matthew Hewitt raised the price target on Simulations Plus (NASDAQ: SLP) to $55.00 (from $53.00) while maintaining a Buy rating following strong Q1.

... More